Key facts
- This page summarizes W. Shaw Robert's Form 4 filing for ULTRALIFE CORP (ULBI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Nov 2025, 09:58.
W. Shaw Robert - 24 Nov 2025 Form 4 Insider Report for ULTRALIFE CORP (ULBI)
- Reporting relationship
- Director
- Issuer ticker
- ULBI
- Reported as of
- 24 Nov 2025
- Net transaction value
- +$9,922
- SEC form
- 4
- Accepted by SEC
- 26 Nov 2025, 09:58:19 UTC
- Prior SEC filing
- 14 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Philip Fain - Attorney-In-Fact for Robert Shaw
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
W. Shaw Robert filed Form 4 for ULTRALIFE CORP (ULBI) on 26 Nov 2025.
Change
- Previous filing in this sequence was filed on 14 May 2025.
- Current net transaction value: +$9,922.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001493772
Primary reporting owner
Robert W. Shaw
- Relationship
- Director
- Address
- 2000 TECHNOLOGY PARKWAY, NEWARK
- Signature
- /s/ Philip Fain - Attorney-In-Fact for Robert Shaw
- Signature date
- 24 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ULBI
transaction
Common Stock; $.10 par value
Purchase
- Transaction value
- $9,922
- Shares
- +1,750
- Change %
- +2.5%
- Price
- $5.67
- Shares after
- 71,000
- Date
- 24 Nov 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.